Polycystic liver disease

Polycystic liver disease
Polycystic liver disease
	Micrograph showing a von Meyenburg complex, a bile duct hamartoma associated with polycystic liver disease. Trichrome stain.
Specialty	Medical genetics

Polycystic liver disease (PLD) usually describes the presence of multiple cysts scattered throughout normal liver tissue.^[1] PLD is commonly seen in association with autosomal-dominant polycystic kidney disease, with a prevalence of 1 in 400 to 1000, and accounts for 8–10% of all cases of end-stage renal disease.^[2] The much rarer autosomal-dominant polycystic liver disease will progress without any kidney involvement.^[2]

Presentation

Pathophysiology

Associations with PRKCSH and SEC63 have been described.^[3] Polycystic liver disease comes in two forms: autosomal dominant polycystic kidney disease (with kidney cysts) and autosomal dominant polycystic liver disease (liver cysts only).^{[citation needed]}

Diagnosis

Most patients with PLD are asymptomatic with simple cysts found following routine investigations. After confirming the presence of cysts in the liver, laboratory tests may be ordered to check for liver function including bilirubin, alkaline phosphatase, alanine aminotransferase, and prothrombin time.^[2]

Patients with PLD often have an enlarged liver which will compress adjacent organs, leading to nausea, respiratory issues, and limited physical ability. Classification of the progression of the disease takes into consideration the amount of remaining liver parenchyma compared to the amount and size of cysts.^[2]

Polycystic liver disease can exist either as isolated polycystic liver disease (PCLD), part of autosomal dominant polycystic kidney disease (ADPKD), or autosomal recessive polycystic kidney disease (ARPKD).^[4]

Treatment

Many patients are asymptomatic and thus are not candidates for surgery. For patients with pain or complications from the cysts, the goal of treatment is to reduce the size of cysts while protecting the functioning liver parenchyma.^[2]

Cysts may be removed surgically or by using aspiration sclerotherapy.^[2]

References

^ Kelly DA (2009). Diseases of the Liver and Biliary System in Children. John Wiley & Sons. p. 239. ISBN 978-1-4443-0054-3. Retrieved 7 March 2018.
^ ^a ^b ^c ^d ^e ^f Poston GJ, D'Angelica M, Adam R (2010). Surgical Management of Hepatobiliary and Pancreatic Disorders, Second Edition. CRC Press. p. 303. ISBN 978-1-84184-760-3. Retrieved 7 March 2018.
^ Online Mendelian Inheritance in Man (OMIM): 174050
^ Zhang ZY, Wang ZM, Huang Y (March 2020). "Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management". World Journal of Hepatology. 12 (3): 72–83. doi:10.4254/wjh.v12.i3.72. PMC 7097502. PMID 32231761.

External links

[1] Kelly DA (2009). Diseases of the Liver and Biliary System in Children. John Wiley & Sons. p. 239. ISBN 978-1-4443-0054-3. Retrieved 7 March 2018.

[poston-2] ^ ^a ^b ^c ^d ^e ^f Poston GJ, D'Angelica M, Adam R (2010). Surgical Management of Hepatobiliary and Pancreatic Disorders, Second Edition. CRC Press. p. 303. ISBN 978-1-84184-760-3. Retrieved 7 March 2018.

[3] Online Mendelian Inheritance in Man (OMIM): 174050

[4] Zhang ZY, Wang ZM, Huang Y (March 2020). "Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management". World Journal of Hepatology. 12 (3): 72–83. doi:10.4254/wjh.v12.i3.72. PMC 7097502. PMID 32231761.

[1]